Team:EPF Lausanne/Calendar/16 September 2013

From 2013.igem.org

(Difference between revisions)
(Created page with "{{Template:EPFL2013Header}} Sensing <BR> '''Seuqencing of the hya promoter plasmid''' <BR> I send the newly isolated and purified hya-containing plasmid for sequencing. '''Tra...")
Line 9: Line 9:
Because the functional assays of the sensing module were inconclusive, I decided to do another transformation with the Plasmids that I had sent for sequencing and whose results showed that the promoters were really present, namely the cad-promoter and the constitutive promoter from iGEM.
Because the functional assays of the sensing module were inconclusive, I decided to do another transformation with the Plasmids that I had sent for sequencing and whose results showed that the promoters were really present, namely the cad-promoter and the constitutive promoter from iGEM.
 +
 +
 +
'''Nanoparticles'''
 +
 +
MMP2 digestion assays
{{Template:EPFL2013Footer}}
{{Template:EPFL2013Footer}}

Revision as of 21:29, 2 October 2013

Taxi.Coli: Smart Drug Delivery iGEM EPFL

Header

Sensing

Seuqencing of the hya promoter plasmid
I send the newly isolated and purified hya-containing plasmid for sequencing.

Transformation Because the functional assays of the sensing module were inconclusive, I decided to do another transformation with the Plasmids that I had sent for sequencing and whose results showed that the promoters were really present, namely the cad-promoter and the constitutive promoter from iGEM.


Nanoparticles

MMP2 digestion assays